Figure 2.
Summary of Participant Evaluations Throughout the Study Period (n=24*).
A: Visual analogue scale (VAS). B: Oswestry Disability Index (ODI); C: SF-12 Mental Component Score (MCS) (version 1). D: SF-12 Physical Component Score (PCS). E: Morphine Equivalent Units (MEU) opiate usage.
Results are expressed as mean±standard error (SE). Refer to Figure 1 for timing details.
* Three patients stopped treatment during phase 1 only (sometime between months 2 and 11), but remained part of the evaluations throughout the study.